big_run,
I don't know if anyone involved in the Cleveland study owned Quigley's stock, but I rather doubt it. The authors are listed as Sherif B. Mossad, MD; Michael L. Macknin, MD; Sharon V. Medendorp, MPH; and Pamela Mason, BSN, MBA. I don't recognize any of those names as being involved with Quigley, although I haven't researched this in detail. I'm sure that the study was conducted at the Cleveland Clinic to make it independent.
If I remember correctly, the developer of Cold-Eeze owned stock in a privately held firm that eventually became Quigley. I think he was involved in the first clinical study, but that study was never published. I don't think it's uncommon for product developers in small companies to be sole proprietors or beneficial owners of their company. That is after all, the definition of an entrepreneur.
Regards,
Dan |
